The earnings season is in full swing, and tech titans such as Meta Platforms (META), Microsoft (MSFT), and others have reported strong quarterly results, capturing investors' attention. However, a few other under-the-radar stocks are also rapidly growing and have excellent long-term prospects.
Wall Street has high expectations for two such companies: Ocugen (OCGN), a small-cap clinical-stage biopharmaceutical company, and Monday.com (MNDY), a software company. Let’s find out why.
